Sebacia AcneIQ
Commercial- Indications
- Acne vulgaris
Company intelligence / Profile preview
Coronado Aesthetics
Southlake, Texas, United Statescoronadoaesthetics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Coronado Aesthetics markets Sebacia AcneIQ, an FDA-cleared in-office treatment for moderate to severe acne. The procedure uses gold microparticles activated by laser energy to target sebaceous glands. Clinical results show durable improvement lasting up to two years after three treatments over two weeks. The treatment avoids systemic drugs like isotretinoin or hormones and has minimal downtime.
- Therapeutic areas
- Dermatology
- Modalities
- Device (laser-based therapy)Microparticle-based therapy (gold microparticles)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Coronado Aesthetics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coronado Aesthetics.